bioMérieux S.A.
General ticker "BMXMF" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $15.2B (TTM average)
bioMérieux S.A. follows the US Stock Market performance with the rate: 15.8%.
Estimated limits based on current volatility of 0.1%: low 125.27$, high 125.49$
Factors to consider:
- Company pays dividends (annually): last record date 2025-06-10, amount 1.03$ (Y0.82%)
Short-term BMXMF quotes
Long-term BMXMF plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | €3,589.00MM | €3,674.70MM | €3,979.90MM |
| Operating Expenses | €3,001.80MM | €3,235.70MM | €3,391.10MM |
| Operating Income | €587.20MM | €439.00MM | €588.80MM |
| Non-Operating Income | €-6.70MM | €-1.60MM | €-9.50MM |
| Interest Expense | €4.10MM | €1.60MM | €16.56MM |
| R&D Expense | €446.60MM | €540.30MM | €491.50MM |
| Income(Loss) | €580.50MM | €437.40MM | €579.30MM |
| Taxes | €140.10MM | €114.50MM | €154.30MM |
| Profit(Loss)* | €452.40MM | €357.60MM | €432.20MM |
| Stockholders Equity | €3,604.20MM | €3,752.20MM | €4,204.90MM |
| Inventory | €737.20MM | €908.50MM | €1,037.30MM |
| Assets | €5,186.60MM | €5,259.20MM | €5,770.00MM |
| Operating Cash Flow | €475.10MM | €445.40MM | €667.30MM |
| Capital expenditure | €286.70MM | €338.30MM | €345.80MM |
| Investing Cash Flow | €-528.10MM | €-488.80MM | €-359.80MM |
| Financing Cash Flow | €-244.20MM | €-122.30MM | €-212.60MM |
| Earnings Per Share** | €3.84 | €3.01 | €3.67 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.